GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Y-Biologics Inc (XKRX:338840) » Definitions » Pre-Tax Income

Y-Biologics (XKRX:338840) Pre-Tax Income : ₩-18,760 Mil (TTM As of Mar. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Y-Biologics Pre-Tax Income?

Pretax income is the income that a company earns before paying income taxes. Y-Biologics's pretax income for the three months ended in Mar. 2024 was ₩-1,624 Mil. Its pretax income for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-18,760 Mil. Y-Biologics's pretax margin was -142.11%.

During the past 6 years, Y-Biologics's highest Pretax Margin was -148.98%. The lowest was -1047.50%. And the median was -435.04%.


Y-Biologics Pre-Tax Income Historical Data

The historical data trend for Y-Biologics's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Y-Biologics Pre-Tax Income Chart

Y-Biologics Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Pre-Tax Income
Get a 7-Day Free Trial -18,379.06 -11,196.97 -10,028.59 -17,070.89 -18,804.40

Y-Biologics Quarterly Data
Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only -2,920.77 -1,976.01 -540.09 -14,620.31 -1,623.87

Competitive Comparison of Y-Biologics's Pre-Tax Income

For the Biotechnology subindustry, Y-Biologics's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Y-Biologics's Pre-Tax Income Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Y-Biologics's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where Y-Biologics's Pre-Tax Income falls into.



Y-Biologics Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

Y-Biologics's Pretax Income for the fiscal year that ended in Dec. 2022 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-18830.217+0+-103.437+66.796+62.457000000002
=-18,804

Y-Biologics's Pretax Income for the quarter that ended in Mar. 2024 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-2433.529+0+-21.795+135.824+695.632
=-1,624

Pre-Tax Income for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-18,760 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Y-Biologics  (XKRX:338840) Pre-Tax Income Explanation

Y-Biologics's Pretax Margin for the quarter that ended in Mar. 2024 is calculated as

Pretax Margin=Pretax Income/Revenue
=-1623.868/1142.665
=-142.11%

During the past 6 years, Y-Biologics's highest Pretax Margin was -148.98%. The lowest was -1047.50%. And the median was -435.04%.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Y-Biologics Pre-Tax Income Related Terms

Thank you for viewing the detailed overview of Y-Biologics's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Y-Biologics (XKRX:338840) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
No. 715, 17, Tech-ro 4-ro, Yuseong-gu, Daejeon, KOR
Y-Biologics Inc is a company has a variety of development candidate antibodies based on Korea's highest-level antibody discovery platform technology and then independently develops antibody treatments or jointly develops cutting-edge biopharmaceuticals by fusing them with our partner's platform technology. Its main business model is based on a globally competitive antibody discovery platform and consists of development of new bio drug candidates and early technology transfer, and contract research services that generate stable cash flow.

Y-Biologics (XKRX:338840) Headlines

No Headlines